Related Experiment Video
Updated: Jun 22, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Managing toxicities and optimal dosing of targeted drugs in advanced kidney cancer
Abstract:
The toxicities of new, targeted drugs may diminish their effectiveness in advanced kidney cancer if those toxicities are not recognized and properly addressed early in patient treatment. Most of the drug-related toxicities in advanced kidney cancer are manageable with supportive care, obviating a need for long interruptions, dose reductions, or permanent discontinuation of the treatment.
Insights
Early recognition and management of toxicities from new targeted drugs are crucial for maintaining treatment effectiveness in advanced kidney cancer. Fortunately, most drug-related toxicities can be managed with supportive care, avoiding treatment cessation.
Area of Science:
- Oncology
- Pharmacology
- Nephrology
Background:
- New targeted therapies offer promise for advanced kidney cancer.
- Drug-induced toxicities can compromise treatment efficacy if not managed.
- Early identification of adverse events is critical for patient outcomes.
Purpose of the Study:
- To highlight the importance of recognizing and managing toxicities associated with targeted drugs in advanced kidney cancer.
- To emphasize that most toxicities are manageable, allowing treatment continuation.
Main Methods:
- Review of clinical data and literature on targeted therapies for advanced kidney cancer.
- Analysis of common toxicities and their management strategies.
- Assessment of the impact of supportive care on treatment adherence.
Main Results:
- Toxicities from targeted drugs can reduce treatment effectiveness in advanced kidney cancer.
- Proactive management with supportive care is effective in mitigating most adverse events.
- Treatment interruptions, dose reductions, or discontinuations are often unnecessary.
Conclusions:
- Effective management of drug toxicities is essential for optimizing targeted therapy outcomes in advanced kidney cancer.
- Supportive care strategies enable sustained treatment, improving patient prognosis.
- Early intervention for toxicities preserves treatment benefits and patient quality of life.
Related Concept Videos
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Kidney Transplant III: Nursing Management

